Atorvastatin hemicalcium salt
Cat. No. 3776
Alternative Name: Lipitor
Chemical Name: (R,R)-2-(4-Fluorophenyl)-β,δ-dihydrox
Biological ActivityPotent HMG-CoA reductase inhibitor (IC50 = 8 nM). Reduces circulating LDL-C by inhibiting cholesterol biosynthesis and inducing expression of LDL receptors. Inhibits smooth muscle cell proliferation in vitro and exhibits antinociceptive effects in the inflammatory hypernociception model.
Licensing InformationSold for research purposes under agreement from Pfizer Inc.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Turner et al (2007) Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion. J.Cardiovasc.Pharmacol. 50 458. PMID: 18049315.
Santodomingo-Garzon et al (2006) Atorvastatin inhibits inflammatory hypernociception. Br.J.Pharmacol. 149 14. PMID: 16865092.
Vaughan et al (2004) Update on statins: 2003. Circulation 110 886. PMID: 15313959.
Istvan et al (2001) Structural mechanism for statin inhibition of HMG-CoA reductase. Science 292 1160. PMID: 11349148.
If you know of a relevant reference for Atorvastatin hemicalcium salt please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Atorvastatin hemicalcium salt from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: Atorvastatin hemicalcium salt, supplier, HMG-CoA, reductases, inhibitors, inhibits, cholesterol, biosynthesis, LDL, Pfizer, Tocris Bioscience, HMG-CoA Reductase Inhibitor products
Find multiple products by catalog number
New Products in this Area
Irreversible TrxR inhibitorPemetrexed
High affinity dihydrofolate reductase inhibitor; also inhibits thymidylate synthase, GARFT and AICARTD9
Potent thioredoxin reductase (TrxR) inhibitorMK 386
Potent, selective human type 1 5α-reductase inhibitor
September 27 - 30, 2017